Operating profit of Novo Nordisk 2009-2023
The operating profit of Novo Nordisk, a Danish pharmaceutical company focused on is diabetes medication, peaked in 2023, at around 103 billion Danish kroner. Through to 2018, the operating profit fluctuated in the range of 47.2 to 49.4 billion Danish kroner, but increased significantly until 2023.